Sartorius | SRT3 - Capital Ordinário





Capital Ordinário Alterar Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Moderna USD 391M 2M 2025-09
Organon & Co USD 262.65M 2.33M 2026-03
Revvity USD 111.8M 1.57M 2026-03
Sartorius EUR 69.05M 0 2026-06
Tectonic Therapeutic USD 18.83M 92.19K 2026-03
Viatris USD 1.16B 5.27M 2026-03
Xeris Pharmaceuticals USD 172.56M 6.34M 2026-03